For the primary evaluable population ( n = @ for adjunctive edivoxetine and n = @ for adjunctive placebo ) , the treatment groups did not differ significantly on the primary outcome of change from baseline to week @ in the MADRS total score ; the effect size of edivoxetine treatment was @ .